Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700841200 on May 8, 2007

J. Biol. Chem., Vol. 282, Issue 29, 21100-21109, July 20, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/29/21100    most recent
M700841200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beinrohr, L.
Right arrow Articles by Závodszky, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beinrohr, L.
Right arrow Articles by Závodszky, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

C1 Inhibitor Serpin Domain Structure Reveals the Likely Mechanism of Heparin Potentiation and Conformational Disease*Formula

László Beinrohr{ddagger}1, Veronika Harmat§, József Dobó{ddagger}, Zsolt Lörincz{ddagger}, Péter Gál{ddagger}2, and Péter Závodszky{ddagger}3

From the {ddagger}Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Karolina út 29, H-1113 Budapest, Hungary and the §Protein Modeling Group and Laboratory of Structural Chemistry and Biology, Institute of Chemistry, Eötvös Loránd University, Hungarian Academy of Sciences, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary

C1 inhibitor, a member of the serpin family, is a major down-regulator of inflammatory processes in blood. Genetic deficiency of C1 inhibitor results in hereditary angioedema, a dominantly inheritable, potentially lethal disease. Here we report the first crystal structure of the serpin domain of human C1 inhibitor, representing a previously unreported latent form, which explains functional consequences of several naturally occurring mutations, two of which are discussed in detail. The presented structure displays a novel conformation with a seven-stranded beta-sheet A. The unique conformation of the C-terminal six residues suggests its potential role as a barrier in the active-latent transition. On the basis of surface charge pattern, heparin affinity measurements, and docking of a heparin disaccharide, a heparin binding site is proposed in the contact area of the serpin-proteinase encounter complex. We show how polyanions change the activity of the C1 inhibitor by a novel "sandwich" mechanism, explaining earlier reaction kinetic and mutagenesis studies. These results may help to improve therapeutic C1 inhibitor preparations used in the treatment of hereditary angioedema, organ transplant rejection, and heart attack.


Received for publication, January 29, 2007 , and in revised form, April 11, 2007.

The atomic coordinates and structure factors (code 2OAY) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by the European Community-Research Infrastructure Action under the FP6 "Structuring the European Research Area Programme" contract RII3-CT-2004–506008; Hungarian Ministry of Health Grant ETT; Hungarian National Science Foundation (OTKA) Grants T046444, T096912, D42199, and NI-61915; and the János Bolyai postdoctoral fellowship (to Z. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Figs. S1–S4.

1 To whom correspondence may be addressed. Tel.: 36-1-209-3535; Fax: 36-1-466-5465; E-mail: lbeinrohr{at}enzim.hu. 2 To whom correspondence may be addressed. Tel.: 36-1-209-3535; Fax: 36-1-466-5465; E-mail: gal{at}enzim.hu. 3 To whom correspondence may be addressed. Tel.: 36-1-209-3535; Fax: 36-1-466-5465; E-mail: zxp{at}enzim.hu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Dobo, V. Harmat, L. Beinrohr, E. Sebestyen, P. Zavodszky, and P. Gal
MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity
J. Immunol., July 15, 2009; 183(2): 1207 - 1214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement